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1. Introduction
  As per World Health Organization (WHO) reports, infectious 
diseases are responsible for over 50% deaths worldwide, 
occurring mainly in tropical and developing countries[1]. 
Socioeconomic conditions and unavailability of modern 
medicine are the main reasons for the people in these areas 
to rely on traditional medicine[1,2]. Many recent studies 
showed significant agreement between the traditional use of 
the plants by indigenous people in the treatment of specific 
symptoms and experimental anti-bacterial, anti-fungal, 
anti-cancer and anti-viral activities in the laboratory[3]. 
Furthermore, medicinal plant derived modern drugs such 
as quinine, vincristine, digoxin and digitoxin, emetine 
and artemisinine are considered as novel pharmaceutical 
compounds. A report by Gen showed that out of the 104 
compounds that are used globally as drugs over 37 years, 
Objective: To evaluate in vitro antimicrobial activities of selected 58 ethno-medicinal plant 
extracts with a view to assess their therapeutic potential. Methods: A total of 58 traditional Chinese 
medicinal plants were carefully selected based on the literature review and their traditional use. 
The antimicrobial activities of ethanol extracts of these medicinal plants were tested against 
fungi (Aspergillus fumigatus), yeast (Candida albicans), gram-negative (Acinetobacter baumannii 
and Pseudomonas aeruginosa) and gram-positive bacteria (Staphylococcus aureus). The activities 
were tested at three different concentrations of 1.00, 0.10 and 0.01 mg/mL. The data was analysed 
using Gene data Screener program. Results: The measured antimicrobial activities indicated 
that out of the 58 plant extracts, 15 extracts showed anti-fungal activity and 23 extracts exhibited 
anti-bacterial activity. Eight plant extracts have exhibited both anti-bacterial and anti-fungal 
activities. For instance, Eucommia ulmoides, Polygonum cuspidatum, Poria cocos and Uncaria 
rhyncophylla showed activity against both bacterial and fungal strains, indicating their broad 
spectrum of activity. Conclusions: The results revealed that the ethanol extracts of 30 plants 
out of the selected 58 possess significant antimicrobial activities. It is interesting to note that 
the findings from the current study are consistent with the traditional use. A clear correlation 
has also been found between the antimicrobial activity and the flavonoid content of the plant 
extracts which is in agreement with the literature. Hence, the results presented here can be used 
to guide the selection of potential plant species for the isolation and structure elucidation of novel 
antimicrobial compounds in order to establish the structure-activity relationship. This in turn is 
expected to lead the way to the discovery of novel antimicrobial agents for therapeutic use.
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60 of them originated from traditional Chinese medicinal 
plants[4]. More recent reports reveal that some of the plant-
derived flavonoids are extremely active at nanomolar 
levels against certain bacteria and are more active than 
well established antibiotics such as vancomycin and 
tetracycline[1-5]. Hence, screening of medicinal plants for 
their bioactivity is extremely important to identify promising 
candidates that are sources of potential therapeutic agents[1]. 
  The epidemiology of invasive infections has significantly 
changed in the last 30 years. As a result, mycoses and 
bacterial illnesses are currently considered as emerging 
diseases. This is an important area that demands the 
discovery of new and effective anti-microbial agents to 
tackle antibiotic resistant strains of pathogens. Amongst 
several such pathogenic species, the most significant 
ones are (i) Aspergillus fumigatus (A. fumigatus), because 
of which mortality rate has steadily risen due to invasive 
aspergillosis, with a 357% increase from 1980-1997[6]; (ii) 
Candida albicans (C. albicans) is seen in almost all of the 
17% of patients treated in the intensive care units who 
develop invasive fungal infections which are associated with 
significant morbidity and mortality[6,7]; (iii) Staphylococcus 
aureus (S. aureus) is a facultative anaerobic gram-positive 
coccal bacterium and it is one of the five most common 
causes of nosocomial postsurgical wound infections[8,9]; 
(iv) Pseudomonas aeruginosa (P. aeruginosa), a gram-
negative bacteria, occasionally associated with opportunistic 
diseases of humans[10]; and (v) Acinetobacter baumannii (A. 
baumannii), which is also a gram-negative bacterium that 
is resistant to most antibiotics[11,12] and the most relevant 
human pathogen within the Acinetobacter genus. Medicinal 
plant based anti-microbial agents are increasingly showing 
their importance to tackle these invasive infections[5], and 
systematic screening programs will be extremely useful in 
this direction. 
  Therefore, the search for new anti-microbial agents is a 
high priority, especially in the tropical countries and other 
developing nations where infectious diseases are rampant[13]. 
Hence, the identification of new sources of anti-microbial 
compounds is an important task for the drug development 
and the innovative strategies that will contribute to 
the improvement of screening protocols are constantly 
evolving[14].
  The approach for  select ing plants  varies from 
random selection to more guided strategies such as 
ethnopharmacological experience derived from traditional 
practice. In the current study, some plants are carefully 
selected on the basis of their ethnopharmacological and 
traditional medicinal use[15,16]. In this study, the ethanol 
extracts of 58 traditional medicinal plants were tested 
against five microbial strains, i.e., A. fumigatus, C. albicans, 
A. baumannii, P. aeruginosa and S. aureus using standard 
anti-microbial assays.
2. Materials and methods
2.1. Collection of medicinal plants
 
  The dried plant materials were purchased from Beijing 
Tong Ren Tang Chinese Herbal Medicine shop, Sydney, 
Australia. The scientific names and family names are given 
in Tables 1-3. The plant materials were ground to a fine 
powder in a grinder before extraction.
2.2. Preparation of the ethanol extract
  Powdered samples were extracted with 95% (v/v) ethanol 
Table 1
List of plant species which showed activity in this study and also have known/reported anti-microbial activity.
S. No Plant species Family Traditional use
1 Alpinae officinarum Zingaberaceae Anti-fungal[34]
2 Eucommia ulmoides Oliv. Eucommiaceae Engler. Anti-fungal[28]
3 Hedyotis diffusa Willd. Rubiaceae Anti-microbial[35]
4 Ligustrum lucidum Ait. Moraceae Anti-microbial[35]
5 Mahonia fortunei (Lindl.) Fedde Berberidaceae Anti-fungal[32]
6 Paeouis suffuticosa Sndr. Ranunculaceae Anti-microbial[35]
7 Paris polyphylla Trilliaceae Anti-fungal[33]
8 Pleione bulbocadioides (Franch.) Rolfe. Orchidaceae Anti-bacterial[36]
9 Ploygala tenuifolia Willd. Polygalaceae Anti-microbial[35]
10 Polygonum aviculare L. Polygonaceae Anti-microbial[37]
11 Polygonum cuspidatum Polygonaceae Anti-viral[35]
12 Pseudostellaria heterophylla (Miq.) Pax ex Pax et Hoffm. Caryophyllaceae Anti-fungal[30]
13 Sarcandra glabra (Thunb.) Nakai Chloranthaceae Anti-microbial[34]
14 Schizandra chinensis (Turcz.) Baill. Schisandraceae Anti-viral[34]
15 Scutellaria barbata Don. Labiatae Anti-microbial[29]
16 Solanum nigrum L. Solanaceae Anti-microbial[35]
17 Codonopsis pilosula Franch. Cam-panulaceae Anti-microbial, anti-oxidant[38]
18 Akebia quinata (Houtt.) Decne. Lardizabalaceae Anti-bacterial[35]
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Table 2
List of plant species which showed activity in this study, but without reported antimicrobial activity.
S. No Plant species Family Traditional use
1 Acanltopanax senticosus Araliaceae No appropriate literature
2 Artemisia vulgaris L. Asteraceae Emmenagogue[39]
3 Aster tataricus L. Asteraceae Anti-tumour[35]
4 Atractylodes macrocephala Koidz. Compositae Anti-tumour[35]
5 Cynanchum paniculatum (Bge.) Kitag Asclepiadaceae Anti-proliferative properties[40]
6 Lysinachia christinae Hance. Lysimachia Anti-cancer[35]
7 Poria cocos (Schw.) Wolf Polyporaceae Anti-cancer[35]
8 Saposhnikovia divaricata (Turcz.) Schischk Apiaceae Anti-cancer[41]
9 Semen coicis L. Poaceae Anti-cancer[35]
10 Smilax glabra Roxb Smilacaceae Anti-cancer[35]
11 Tussilago farfara L. Asteraceae Antiseptic; antiphlogistic[42]
12 Uncaria rhyncophylla Rubiaceae Ant ipy re t i c ,  an t i-hyper t ens i ve  and 
anticonvulsant[43]
Table 3
List of plant species which did not show activity in this study.
S. No Plant species Family Traditional use
1 Actinidia arguta (Sieb.et Zucc.) Flarich.ex Miq. Actinidiaceae Anti-lipase[44]
2 Andrographis paniculata (Burm.f.) Wall. ex Nees Acanthaceae Anti-inflammatory and anti-pyretic effect[45]
3 Asparagus cochinchinensis (Lour.) Merr. Asparagaceae Anti-cancer[35]
4 Corydalis yanhusuo W. Papaveraceae Anti-cancer[35]
5 Curcuma aromatica Zingiberaceae Anti-cancer[35]
6 Curcuma zedoaria (Christm.) Roscoe Zingiberaceae Anti-bacterial[35]
7 Cyperus rotundus L. Cyperaceae Anti-bacterial[35]
8 Ducheshea indica (Andr.) Focke. Rosaceae Anti-cancer[35]
9 Leonurus japonicus Houtt. Labiatae Anti-tumour[35]
10 Lobelia chinensis Lour. Campanulaceae Anti-cancer[46]
11 Paeonia lactiflora Pall. Paeoniaceae Anti-inflammatory[35]
12 Pinellia ternate (Thunb.) Breit. Araceae Anti-tumour[35]
13 Plantago asiatica L. Plantaginaceae Anti-inflammatory[35]
14 Platycodon grandiflorus (Jacq.) A. DC. Campanulaceae Anti-inflammatory[35]
15 Pogostemon cablin Benth. Asteraceae Anti-fungal[35]
16 Prunella vulgaris L. Lamiaceae Anti-bacterial[35]
17 Rabdosia rubescens (Hamst) Hara. Labiatae Anti-inflammatory[35]
18 Rehmannia glutinosa (Gaertn.) Steud. Phrymaceae Anti-tumour[35]
19 Rheum officinale L. Polygonaceae Anti-tumour[35]
20 Salvia miltiorrhiza Bunge. Caspase Anti-tumour[35]
21 Sanguisorba officinalis L. Rosaceae Antimicrobial[42]
22 Scutellaria baicalensis Georgi. Labiatae Anti-tumour[35]
23 Solanum lyratum Thunb. Solanaceae Anti-tumour[34]
24 Sophora flavescens Ait. Fabaceae Anti-inflammatory[35]
25 Sophora japonica (L.) Schott. Fabaceae Anti-tumour[35]
26 Spatholobus suberectus Dunn. Leguminosae Anti-bacterial[35]
27 Taxillus chinensis (DC.) Danser Loranthaceae Anti-virus[35]
28 Viscum coloratum (Komar.) Nakai Viscaceae Anti-tumour[47]
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on water bath at 70 °C for 6 h. The extracted samples were 
centrifuged and the supernatant was transferred into a 50 mL 
volumetric flask and adjusted the volume to 50 mL with 95% 
(v/v) ethanol. The samples were stored at -4 °C until testing. 
All extracts were filtered and dried to remove the solvent 
prior to the analysis. Dried extracts have been re-dissolved 
into appropriate sterile solvent before testing. Three different 
concentrations (1.00, 0.10 and 0.01 mg/mL) of each plant 
extract was prepared for screening anti-microbial activities.
2.3. Test microorganisms 
 
  In the present study, three bacterial strains and two fungal 
strains were used for assay. Anti-bacterial susceptibility 
was tested with the strains S. aureus MSSA (methicillin 
susceptible) EPI167[17], A. baumannii, a clinical isolate from 
MEDINA’s Culture Collection, and P. aeruginosa PAO-1[18]. 
Anti-fungal susceptibility was tested with the strains C. 
albicans, clinical isolate from MEDINA’s Culture Collection, 
A. fumigatus ATCC 46645 (wild-type strain) and A. fumigatus 
∆akuBKU80 (lacking the non-homologous end joining 
pathway)[19].
2.4. Anti-infective assay on A. baumannii
  Thawed stock inoculum suspension from cryovial were 
streaked onto Luria-Bertani agar plates (LBA, 40 g/L) and 
incubated at 37 °C overnight to obtain isolated colonies. Single 
colonies of A. baumannii were selected to inoculate an overnight 
culture to be used as assay plate inoculums. The single colonies 
were inoculated into Erlenmeyer flasks containing 10 mL Luria-
Bertani broth medium (LB, 25 g/L in 250 mL). The flasks were 
incubated overnight at 37 °C with shaking at 220 r/min and 
were suspended until the absorbance at OD612 was adjusted 
to 0.35 in LB media and then diluted to 1:10 000 in order to 
obtain assay inoculums of approximately 5-6伊105 CFU/mL. For 
the screening assay, 90 毺L of the diluted inoculums were 
mixed with 10 毺L of herbal extracts as well as ciprofloxacin 
and amphotericin B were included as internal plate controls. 
Pipetting and mixing were performed in a Tecan AQUARIUS 
pipetting station (Tecan, Durham, USA) and the plates 
used were microtiter 96-plates Costar 3370 (Corning, NY, 
USA). The absorbance at OD612 was measured with a Tecan 
UltraEvolution spectrophotometer (Tecan, Durham, USA) 
at T0 (zero time) and immediately after that, plates were 
statically incubated at 37 °C for 18-20 h. After incubation, 
the test plates were shaken using the DPC Micromix-5 and 
once more the absorbance at OD612 was measured at Tf (final 
time). Percentage inhibition of growth was calculated using 
the following normalization equation:
Percentage inhibition (%) = 100伊{1-[(Tf Sample-T0 Sample)-(Tf 
Blank-T0 Blank)]/[(Tf Growth-T0 Growth)-(Tf Blank-T0 Blank)]}.                       (1)  
Where, T0 Sample = the absorbance of the strain growth in 
the presence of sample measured at zero time (before 
incubation); 
T f Sample = the absorbance of the strain growth in the 
presence of sample measured at final time (after 
incubation);
T0 Growth = the absorbance of the strain growth in the 
absence of sample measured at zero time (before 
incubation);
T f Growth = the absorbance of the strain growth in the 
absence of  sample measured at  f inal t ime (after 
incubation); 
T0 Blank = the absorbance of the broth medium (blank) 
measured at zero time (before incubation);
Tf Blank = the absorbance of the broth medium (blank) 
measured at final time (after incubation).
  An extract was considered to have activity when its 
percentage of inhibition was more than 60%.
2.5. Anti-infective assay on S. aureus
  Frozen stocks were used to inoculate LB agar plates containing 
15 毺g/mL of chloramphenicol for confluent growth. Plates 
were incubated for 18-20 h at 37 °C. The grown colonies of S. 
aureus were harvested from the LB agar plates and suspended 
in LB broth medium until the absorbance at OD600 was adjusted 
to 0.3. This inoculum was used to make a second dilution of 
1:100 (containing 34 毺g/mL of chloramphenicol) of which the 
concentration was approximately 6伊105 CFU/mL. Screening 
assay was performed as described above for A. baumannii. 
Amphotericin B and penicillin G were used respectively 
as negative and positive controls at each plate. Percentage 
of growth inhibition was calculated using the same 
normalization equation as that for A. baumannii. An extract 
was considered to have activity when its percentage of 
inhibition was more than 60%.
2.6. Anti-infective assay on P. aeruginosa
  Thawed stock inoculum suspension from cryovials was 
streaked onto LB agar plates and incubated at 37 °C 
overnight to obtain isolated colonies. Single colonies of P. 
aeruginosa were selected to inoculate an overnight culture to 
be used as assay plate inoculums. The single colonies were 
inoculated into 10 mL LB medium in 250 mL Erlenmeyer 
flasks. The flasks were incubated overnight at 37 °C with 
shaking at 220 r/min. The overnight culture is adjusted to 
obtain an assay inoculum of approximately 5伊105 CFU/mL. As 
reference, the OD600 of a 1:20 dilution of the overnight culture 
is 0.35. Screening assay was performed as described above 
for A. baumannii. Ciprofloxacin and amphotericin B were 
used as internal controls at each plate. Percentage of growth 
inhibition was calculated using the same normalization 
equation as that for A. baumannii. An extract was considered 
to have activity when its percentage of inhibition was more 
than 60%.
2.7. Anti-infective assay on C. albicans
  Thawed stock inoculums suspensions from cryovials were 
streaked on Sabouraud Dextrose Agar (SDA, 65 g/L) plates 
for confluent growth. Plates were incubated for 18 h at 37 °C. 
The C. albicans colonies were harvested from the SDA plates 
and suspended in RPMI-1640 modified medium in order to 
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prepare an inoculum adjusted to an optical density of 0.25 
at 660 nm. Modified medium RPMI-1640 was prepared as 
follows: 20.8 g of RPMI powder (Sigma) was poured into a 2 
L flask, together with 13.4 g of YNB, 1.8 L of Milli-Q water, 
80 mL of 1 mol/L Hepes and 72 mL of 500 g/L glucose. The 
volume was adjusted at 2 L and filtered. 
  The adjusted suspension was diluted 1:10 and kept on 
ice until being used to inoculate 96-well microtiter plates. 
Screening assay was performed as described above for A. 
baumannii. Amphotericin B and penicillin G were used 
respectively as positive and negative controls at each plate. 
Percentage of growth inhibition was calculated using the 
same normalization equation as that for A. baumannii. An 
extract was considered to have activity when its percentage 
of inhibition was more than 60%.
2.8. Anti-infective assay on A. fumigatus
  The high throughput A. fumigatus susceptibility assay was 
applied on two stains, A. fumigatus ATCC 46645 (wild-type 
strain) and A. fumigatus ∆akuBKU80, generally used in genetic 
manipulation experiments. Anti-fungal activity was scored 
using resazurin, a non-fluorescent blue dye that reduction is 
converted to the pink colored highly fluorescent. Resazurin 
is an oxidation-reduction indicator of eukaryotic cell 
viability and its utility for assessing cell viabilities has been 
demonstrated[20,21].
  For testing of A. fumigatus isolates, a conidial suspension 
was prepared after subculture on PDA medium. The 
colonies were harvested from the PDA plates and 
suspended in RPMI-1640 modified medium[22]. Modified 
medium RPMI-1640 was prepared as describes above for 
C. albicans. The inoculum concentration size was ~2.5伊104 
CFU/mL (determined by counting in a Neubauer chamber) 
and resazurin was at final concentration of 0.02 g/L. For the 
screening assay, 7 毺L/well of the samples and 150 毺L/well 
of the inoculum were dispensed in 96-well microtiter 
plates. Amphotericin B was used as positive control. After 
dispensing the plates were statically incubated at 37 °C for 
25-30 h.
  After incubation, the plates were read on VICTOR2 
multilabel counter (Perkin Elmer™) using wavelength 
settings for resazurin (excitation 570 nm, emission 600 nm). 
The percentage of resazurin reduction and growth inhibition 
was calculated using the following normalization equations: 
Percentage of reduction (%) = (Fluorescent intensity of test 
agent-Fluorescent intensity of untreated control)/(Fluorescent 
intensity of reduced resazurin-Fluorescent intensity of 
untreated control)伊100                                                            (2)
Percentage of inhibition (%) = 100-Percentage of reduction   (3)
  The extract was considered to have activity when its 
percentage of inhibition was more than 60%. 
2.9. Statistical analysis
  The anti-microbial screening data were analysed using the 
Genedata Screener program (Genedata AG, Switzerland). The 
Z’ factor predicts the robustness of an assay by taking into 
account the mean and standard deviation of both positive 
and negative controls. The Z’ factors were calculated using 
the equation: 
Z´= 1-[3伊(σp-σn)/(μp-μn)].                                                 (4)
Where, p is the measured parameter with positive control, 
n is the measured parameter with negative control, σ is the 
standard deviation and μ in the mean. 
  In general, a Z’ factor value between 0.5-1.0 are considered 
an excellent assay[23]. The Robust Z’ factor (RZ’ factor) is 
based on the same formula as the Z’ factor, but standard 
deviations and means are replaced by the robust standard 
deviations and medians, respectively. In all experiments 
performed in this work, the RZ’ factor obtained was between 
0.85-0.95. The comparative analysis of various data sets was 
done using statistical correlation. 
3. Results 
  In this study, the ethanol extracts of 58 plants belonging 
to 45 families were examined for their activity against 
fungi, yeast, gram-negative and gram-positive bacteria (A. 
fumigatus, C. albicans, A. bumanni, P. aeruginosa and S. 
aureus). A total of 30 plant extracts showed significant anti-
microbial activities against these test microbial strains.
3.1. Anti-fungal activity of selected plant extracts 
  The anti-fungal activities of the selected plant extracts 
were tested against two kinds of fungal species, namely, 
C. albicans representing the yeast model and A. fumigatus 
representating filamentous fungus. The activities of these 
extracts were evaluated in a dose-response curve with 
1.00, 0.10 and 0.01 mg/mL concentrations. These results 
are presented in Table 4. These results revealed that 13 
plant extracts, namely, Solanum nigrum, Poria cocos (P. 
cocos), Eucommia ulmoides (E. ulmoides), Atractylodes 
macrocephala, Polygonum cuspidatum (P. cuspidatum), 
Ligustrum lucidum, Ploygala tenuifolia, Saposhnikovia 
divaricata, Mahonia fortunei, Cynanchum paniculatum, 
Lobelia chinensis, Aster tataricus and Uncaria rhyncophylla 
(U. rhyncophylla), showed high inhibition activity against 
A. fumigatus (that represents filamentous fungus). However, 
only two plant extracts, namely, Codonopsis pilosula and 
Tussilago farfara, showed high inhibition effect against 
C. albicans (that represents the yeast model). These anti-
fungal activities suggest that different plant extracts may 
contain very selective target compounds that have specific 
selectivity towards A. fumigatus and C. albicans. The 
results are very significant as most of the plants showed an 
inhibitory effect not only at the concentration of 1.00 mg/mL 
but also at 0.10 mg/mL. 
3.2. Anti-bacterial activity of selected plant extracts against 
gram-negative bacteria
  The strains used for the gram-negative assay were A. 
baumannii and P. aeruginosa PAO-1 from MEDINA’s Culture 
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Collection. The inhibition effects of the plant extracts against 
these two strains are tabulated in Table 5. The dose response 
curve was constructed with three dilution points at 1.00, 0.10 
and 0.01 mg/mL. The plant extracts of Artemisia vulgaris (A. 
vulgaris), Sarcandra glabre, Polygonum aviculare, Akebia 
quinata and Scutellaria barbata (S. barbata) exhibited high 
inhibitory activity against both of the gram-negative strains 
tested (A. baumannii and P. aeruginosa). On the other 
hand, the extracts of P. cocos, E. ulmoides, P. cuspidatum, 
Acanltopanax senticosus, U. rhyncophylla and Hedyotis 
diffusa showed significant inhibitory activity against only A. 
baumannii bacteria. High anti-bacterial activity (towards 
gram-negative bacteria) of tweleve plant extracts out of 58, 
against A. baumannii compare to P. aeruginosa bacteria is 
an extremely important finding.
3.3. Anti-bacterial activity of selected plant extracts against 
gram-positive bacteria
  S. aureus EPI-167 was used in this study as representative 
gram-positive bacteria. The inhibitory effects of plant 
extracts against this strain are presented in Table 6. Several 
plant extracts were found to inhibite the proliferation of this 
gram-positive bacterium at the concentration of 1.00 mg/mL. 
Twenty-three plant extracts out of 58 showed a significant 
inhibitory effect against S. aureus. Noticeably, all of the 
extracts that showed inhibitory effect in gram-negative 
bacteria also exhibited their activity against gram-positive 
bacteria indicating that these plant extracts may have a 
broad spectrum of anti-microbial activities. 
Table 5
Anti-bacterial activities of medicinal plant extracts towards Acinetobact baumannii and Pseudomon aeruginosa (gram-negative bacteria) (%).
S. No Plant species
A. baumannii MEDINA collection strain P. aeruginosa PAO-1 strain
1.00 mg/mL 0.10 mg/mL 0.01 mg/mL 1.00 mg/mL 0.10 mg/mL 0.01 mg/mL
1 Artemisia vulgaris 98±1 48±2 15±3 65±5 8±0 4±1
2 Sarcandra glabra 73±2 37±6   4±3 53±2 5±5 2±3
3 Poria cocos        126±8 66±3 23±8             7±9 3±1 6±1
4 Eucommia ulmoides        134±2 60±3   5±8  37±33 3±2 5±1
5 Polygonum cuspidatum 60±6    1±10   8±4  24±11 4±2          10±0
6 Polygonum aviculare 81±3 45±4   6±7           74±6 9±0 4±1
7 Akebia quinata 71±5 47±7     5±10 66±2          11±2 8±1
8 Alpinae officinarum 88±7 23±2     6±11 32±9 2±2 1±0
9 Scutellaria barbata 90±5 32±3          18±4 49±5 6±1 7±1
10 Acanltopanax senticosus   94±25 45±4   1±2   31±14 1±1 2±1
11 Uncaria rhyncophylla   62±11   20±14   6±3   2±8 6±1 8±2
12 Hedyotis diffusa   94±21 45±8          17±5 26±1 2±1 4±0
All data are expressed as mean±SEM. Mean: Mean value of % inhibition of growth.
Table 4
Anti-fungal activities of medicinal plant extracts towards Aspergillus fumigatus and Candida albicans (%). 
S. No Plant species
A. fumigatus ATCC 46645 and ∆akuBKU80 strains C. albicans MEDINA collection strain
1.00 mg/mL 0.10 mg/mL 0.01 mg/mL 1.00 mg/mL 0.10 mg/mL 0.01 mg/mL
1 Solanum nigrum 66±4 30±5 10±3 14±10   13±2 4±3
2 Poria cocos 88±1 66±6 22±8 17±12   20±2 9±2
3 Codonopsis pilosula 55±2 11±5   4±4       100±0 100±0 4±1
4 Eucommia ulmoides   64±10   40±13   8±6 12±10   10±1 2±2
5 Atractylodes macrocephala 86±1 56±3   3±4 22±13   10±0 4±2
6 Polygonum cuspidatum 63±6   3±5 16±1   1±13     6±1 2±2
7 Ligustrum lucidum 71±4 33±5   5±7   5±14   10±1 3±2
8 Ploygala tenuifolia   69±13 24±6   2±5   0±13   13±1 3±2
9 Saposhnikovia divaricata 70±3 18±8   5±2   1±15   10±1 3±2
10 Mahonia fortunei 93±0 65±1 12±1   7±14    9±2 6±2
11 Cynanchum paniculatum 73±1 50±2 17±4   8±15   5±0 1±2
12 Lobelia chinensis Lour 84±1 55±3 17±6   3±13   7±0 4±3
13 Tussilago farfara   2±2   6±5 15±6          76±3 27±4 5±3
14 Aster tataricus 65±1 36±7 18±7   4±15   9±1 2±3
15 Uncaria rhyncophylla 68±9 42±7   9±6   2±14 12±1 2±2
All data are expressed as mean±SEM. Mean: Mean value of % inhibition of growth. 
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4. Discussion
  Infective diseases due to microbes such as A. fumigatus, 
C. albicans, A. baumannii, P. aeruginosa and S. aureus, are 
extremely prevalent and responsible for mortality around 
the world[1-9]. The mortality rate may continue to increase 
in the future for two reasons: (i) lack of sufficient supply of 
antibiotics in developing countries and (ii) non-availability 
of anti-microbial agents to tackle antibiotic resistant strains 
of pathogens. Medicinal plants have received a significant 
attention as new sources of anti-microbial agents to address 
these issues. The synergistic effect of plant based flavonoids 
in combination with conventional antibiotics is proving to 
be an important new direction in complementary medicine 
research[5]. In this respect, it is important to note that less 
than 10% of higher plant species are analysed for their 
bioactivity[24] and hence present great potential. 
  In the current study, 30 out of the carefully selected 58 
plant species displayed anti-microbial properties against 
one or more microbial strains, while remaining were found 
to be inactive. Of all the 30 active species, 23 plants were 
found to inhibit gram-positive bacterial strains (S. aureus) 
and 12 of these plants also showed inhibition against the 
gram-negative bacteria (A. baumannii and P. aeruginosa). 
On the other hand, 15 plant extracts showed anti-fungal 
properties by inhibiting either A. fumigatus or C. albicans. 
The results suggest that more plants possess anti-bacterial 
properties than anti-fungal properties, while eight plant 
species showed both anti-bacterial and anti-fungal 
properties. Literature strongly support that plants with high 
polyphenols and flavonoids contents display anti-microbial 
properties[5,25]. This further supports the anti-microbial 
activities of some of the plant extracts in the present study 
are likely to be due to their high flavonoid content[26].
  It is interesting to note that some of the plant extracts 
showed their broad spectrum of anti-bacterial activities. 
For instance, the extracts of A. vulgaris, P. aviculare and 
A. quinata showed activity against both gram-positive 
(S. aureus) and gram-negative bacteria (P. aeruginosa 
and A. baumannii). Some plants, namely, E. ulmoides, P. 
cuspidatum, P. cocos and U. rhyncophylla showed activity 
towards both bacterial strains (A. baumannii, and S. aureus) 
and fungal strains (A. fumigatus). 
  Some plants exhibited specificity against specific microbial 
strains. For instance, the anti-fungal activity of many plants 
is more towards the filamentous fungus A. fumigatus while 
the activity is less towards the yeast C. albicans. Seven 
plants, namely, P. heterophylla, P. suffuticosa, S. chinensis, 
A. senticosus, P. polyphylla, P. bulbocadioides and S. coicis, 
showed their specificity against only gram-positive bacteria 
(S. aureus). Plants produce several secondary metabolites 
that include phenolics, flavones, flavonoids, flavonols, 
tannins, coumarins, alkaloids, lectins, polypeptides and 
other compounds and these classes of bioactive compounds 
Table 6
Anti-bacterial activities of medicinal plant extracts towards Staphylococcus aureus (gram positive bacteria) (%).
S. No Plant species
S. aureus EPI-167 strain
1.00 mg/mL 0.10 mg/mL 0.01 mg/mL
1 Artemisia vulgaris   97±1 26±1 0±1
2 Sarcandra glabra   98±1 57±3 2±1
3 Poria cocos 130±7 49±7 0±2
4 Pseudostellaria heterophylla 101±1   8±1 0±2
5 Paeouis suffruticosa 103±3 10±1 1±1
6 Eucommia ulmoides 117±3   85±17 2±1
7 Polygonum cuspidatum 101±2   1±1 1±2
8 Ligustrum lucidum 104±3   8±2 0±1
9 Ploygala tenuifolia   99±1   8±2 4±2
10 Polygonum aviculare 100±0 25±2 2±1
11 Akebia quinata   68±0 38±4 2±2
12 Alpinae officinarum 103±2   16±14 2±1
13 Scutellaria barbata   94±2 14±3 1±3
14 Schizandra chinensis 102±2 11±1 1±1
15 Acanltopanax senticosus 103±1   6±4 1±1
16 Paris polyphylla   99±4   6±2 2±2
17 Smilax glabra   97±0   7±1 1±1
18 Pleione bulbocadioides   99±4   36±11 2±1
19 Tussilago farfara 105±1   6±2 1±2
20 Aster tataricus   97±0   9±1 1±1
21 Uncaria rhyncophylla   99±1 12±2 1±1
22 Hedyotis diffusa     61±13 16±1                 11±3
23 Semen coicis   97±3 17±2 5±2
All data are expressed as mean±SEM. Mean: Mean value of % inhibition of growth. 
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support the plant defence against the predators such 
as microorganisms, insects and herbivores[25]. These 
compounds have also been confirmed in the literature 
to possess anti-oxidant, anti-inflammatory and anti-
infectious properties[5,25,26]. Plants with high concentrations 
of flavonoids have been established in previous studies to 
possess anti-microbial activity[5,25,26]. Consistent with the 
literature, some of the active plants reported in this paper 
have significant levels of flavonoid content[26]. It can be 
assumed that the varied activities of the plants studied here 
could be mainly due to the presence of differing quantities 
of lead anti-microbial compounds[1]. Further bioassay 
guided fractionation; isolation and characterization of major 
bioactive constituents is likely to provide an answer to this 
synergism. 
  The results presented in this paper strongly support anti-
microbial properties of many of the plants studied. Most of 
the extracts of plants were used traditionally in the form of 
formulations/individual extracts to treat viral, bacterial and 
fungal infectious diseases or related symptoms. Interestingly, 
these plants displayed significant anti-bacterial or anti-
fungal properties, showing concordance with traditional 
use. For example, P. cuspidatum, Sarcandra glabra, Pleione 
bulbocodioides and Alpinia officinarum were traditionally 
used to treat different infectious diseases, and these plants 
showed significant activity against different microbial 
strains.  
  It should be noted that anti-microbial agents have 
been previously isolated from some of the plants studied 
here[27-33]. Two anti-fungal peptides, EAFP1 and EAFP2, 
that were reported from E. ulmoides showed broad spectra 
of anti-fungal activity against eight fungal stains[28]. 
In this study, E. ulmoides has shown significant anti-
fungal activity against filamentous fungus A. fumigatus 
and also anti-bacterial activity against A. baumannii 
and S. aureus strains. These observed activities may 
therefore be attributed to the presence of active peptides 
in this plant. Essential oils including hexahydro-
farnesylacetone, 3,7,11,15-tetramethyl-2-hexadecen-1-
ol, menthol and 1-octen-3-ol, which have been isolated 
from S. barbata showed anti-microbial activity against 17 
microorganisms[29]. Interestingly, the studies carried out by 
Yu et al.[29] and also the results of present study demonstrate 
that S. aureus is highly sensitive to the extract of S. barbata. 
Lectin and a Kunitz-type trypsin inhibitor isolated from P. 
heterophylla exhibited anti-fungal activity towards Fusarium 
oxysporum[30], while this plant showed anti-bacterial activity 
against S. aureus in the present study. 
  Some plants were used as anti-microbial agents in the 
traditional medicine, while these plants did not display 
activity against any of the selected strains. However, the 
plants displayed significant anti-infective properties against 
different microbial strains studied here. To the best of our 
knowledge, the anti-microbial activities of these twelve 
plants are reported for the first time in this study. 
  In summary, amongst the carefully selected 58 traditional 
Chinese medicinal herbs studied in this work, 30 of them 
showed significant anti-microbial activity against different 
microbial strains. Sixteen of active plants confirm their 
promising anti-microbial activity based on the previous 
reports and their traditional use, which is in agreement 
with the current findings. In addition, a good correlation 
has been found between the anti-microbial activity and the 
flavonoid content of some of the plant extracts[26]. Hence, the 
extracts of these 16 plants could be considered as possible 
candidates for anti-microbial drug discovery. The anti-
microbial activities of the twelve plants are reported for 
the first time in this study. Some of the extracts showed no 
activity against any of the microbial strains studied here, 
which might be due to the lack of anti-microbial agents in 
these plants or they may be selectively active against other 
pathogens that are not investigated in this paper. However, 
more studies directed towards the isolation of bioactive 
compounds from active plant extracts, determination of 
their structures, establishing structure-activity relationship, 
evaluation of the mechanism of action and in vivo studies 
including toxicity measurements are expected to lead 
the way towards new anti-microbial drug development. 
Currently, isolation and characterisation of anti-microbial 
agents from U. rhyncophylla and P. cuspidatum is in 
progress in our laboratory.
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